The purpose of the Clinical Trials Support Unit (CTSU) is to provide a central Cancer Center resource tocoordinate and assist with all cancer-related clinical research within the affiliated hospitals and ambulatorycare centers of BCM. It will foster the establishment and maintenance of clinical trial related infrastructure,especially for investigators and institutions with less prior experience and knowledge in this area. By thismechanism, it will enable and increase clinical trial enrollment to a wide spectrum of cancer-related studies.The Unit's efforts will particularly target hospitals and institutions with a higher proportion of minority andeconomically disadvantaged patients, providing greater access to participation in clinical research for thesepopulations. In addition the CTSU will facilitate liaison with external co-investigators and cooperative groups,federal agencies, and the pharmaceutical industry.The CTSU will provide three major services to Cancer Center investigators:1) Assistance with regulatory and administrative matters relating to clinical research and trials includingIRB compliance and approval, ongoing amendments and renewal, external agency compliance (suchas the FDA), maintenance of regulatory files, and assistance with internal and external audits;2) Provision of research nursing/clinical trials management especially to less experienced investigatorsor those with limited programs;3) Provision of data management and bioinformatics expertise including database instruction andmaintenance and internal audits.The CTSU will thus provide efficient, cost-effective support to aid Cancer Center investigators in the conductof scientifically valuable cancer clinical trials and will improve access to these trials, especially forunderserved minorities. The main offices of the CTSU are located within the Cancer Center administrativeoffices on the fourth floor of the Cullen Bldg at Baylor College of Medicine. Satellite offices for ResearchNursing/Research Coordinators are located in each of the College's major affiliated clinical facilities includingthe Baylor Ambulatory Care Clinic, St. Luke's Episcopal Hospital, Texas Children's Hospital, the Ben TaubGeneral Hospital, and the Michael E. DeBakey VA Medical Center. The Resource Leader is Martha Mims,M.D./Ph.D.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
United States
Zip Code
Singh, Sunita; Jangid, Rahul K; Crowder, Alyssa et al. (2018) Foxi3 transcription factor activity is mediated by a C-terminal transactivation domain and regulated by the Protein Phosphatase 2A (PP2A) complex. Sci Rep 8:17249
Lulla, Premal D; Hill, LaQuisa C; Ramos, Carlos A et al. (2018) The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma. Clin Adv Hematol Oncol 16:375-386
De Maio, Antonia; Yalamanchili, Hari Krishna; Adamski, Carolyn J et al. (2018) RBM17 Interacts with U2SURP and CHERP to Regulate Expression and Splicing of RNA-Processing Proteins. Cell Rep 25:726-736.e7
Bayrer, James R; Wang, Hongtao; Nattiv, Roy et al. (2018) LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun 9:4055
Charendoff, ChloƩ I; Bouchier-Hayes, Lisa (2018) Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation. J Vis Exp :
Reineke, Lucas C; Cheema, Shebna A; Dubrulle, Julien et al. (2018) Chronic starvation induces noncanonical pro-death stress granules. J Cell Sci 131:
Zhang, Manqi; Suarez, Egla; Vasquez, Judy L et al. (2018) Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity. Oncogene :
Chiang, Yun-Chen; Park, In-Young; Terzo, Esteban A et al. (2018) SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma. Cancer Res 78:3135-3146
Cardona, Sandra M; Kim, Sangwon V; Church, Kaira A et al. (2018) Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1I249/M280 Variant. Front Cell Neurosci 12:365
Shao, Longjiang; Wang, Jianghua; Karatas, Omer Faruk et al. (2018) Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN. Oncotarget 9:14456-14471

Showing the most recent 10 out of 991 publications